Live Breaking News & Updates on Nemoursai Dupont

Stay updated with breaking news from Nemoursai dupont. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Synaptogenix Provides Corporate Update and Outlines Potential Business Opportunities

/PRNewswire/ Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapeutics. ....

George-perry , Alan-tuchman , Nemoursai-dupont , National-cancer-institute , National-institute-of-health , National-institutes-of-health , Drug-administration , Nasdaq , Synaptogenix-inc , Exchange-commission , Prnewswire-synaptogenix-inc

New leadership for the College of Health Sciences

William Farquhar named next dean of College of Health Sciences ....

Delaware , United-states , University-of-delaware , American , Laura-carlson , Wiliam-farquhar , Darcy-reisman , Kathy-matt , Levi-thompson , Dennis-assanis , Williamb-farquhar , William-farquhar

Health Sciences dean search underway

Search advisory committee appointed to identify next College of Health Sciences dean ....

Kathleen-matt , Dennis-assanis , Joe-fox , Kristi-kiick , Eric-wommack , Elizabeth-inez-kelley , Robin-morgan , Matthew-cohen , Yendelela-cuffee , Nancy-getchell , Leslie-allshouse , David-edwards

MS Trials Being Planned Into Bryostatin-1, Molecule to Protect Synapses

MS Trials Being Planned Into Bryostatin-1, Molecule to Protect Synapses
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Daniel-alkon , Alan-tuchman , Nemoursai-dupont , Petros-pharmaceuticals , Drug-administration , Metuchen-pharmaceuticals , Cleveland-clinic , Pont-hospital ,

Synaptogenix Moves Forward with Clinical Development Plans for Bryostatin-1 as a Treatment for Multiple Sclerosis

/PRNewswire/ Synaptogenix, Inc. (Nasdaq: SNPX), a clinical-stage biopharmaceutical company developing regenerative therapeutics for neurodegenerative. ....

Daniel-alkon , Robert-weinstein , Alan-tuchman , Nemoursai-dupont , Exchange-commission , Drug-administration , Nasdaq , Synaptogenix-inc , Cleveland-clinic , Chief-scientific , Orphan-drug-designation